Background-The presence of syncope in patients with aortic valve stenosis (AS) predicts a grave prognosis. However, the evaluation of AS severity has been limited to valve-specific factors such as aortic valve area and mean transaortic pressure gradient. Recently, valvuloarterial impedance (Zva) was proposed for the estimation of global left ventricular afterload. Therefore, because predictors of syncope in patients with AS have not been investigated in recent years, we assessed the effect of clinical characteristics and echocardiographic parameters, including Zva, on syncope in patients with AS. Methods and Results-We retrospectively studied 451 patients with moderate and severe AS without low left ventricular ejection fraction (<40%). Patients with syncope (n=79; 18%) had higher Zva (5.1±0.9 versus 4.4±0.9 mm Hg/mL per m 2 ; P<0.001) than those without (n=372; 82%). However, no significant differences existed in the mean transaortic pressure gradient (P=0.076) or the aortic valve area (P=0.160) between the 2 groups. In the multivariable analysis, only Zva was an independent predictor of syncope in patients with AS (odds ratio, 2.02; 95% confidence interval, 1.54-2.64; P<0.001). However, systolic blood pressure, relative wall thickness, the early transmitral flow velocity to peak early diastolic mitral annular velocity ratio, and mean transaortic pressure gradient were not identified as independent predictors. Receiver operating characteristic curve analysis identified Zva ≥4.7 mm Hg/mL per m 2 as the cutoff value associated with syncope in patients with AS. Conclusions-Our study suggests that high Zva, but not conventional parameters of AS, identifies AS patients with an increased risk of syncope. (Circ Cardiovasc Imaging. 2013;6:1024-1031.)
S yncope is one of the most serious symptoms of aortic valve stenosis (AS). For the past 50 years, syncope was considered the terminal state of AS. 1 Unexpectedly, however, only a few studies have investigated syncope in patients with AS. [2] [3] [4] Furthermore, AS severity is usually defined on the basis of valve-specific factors such as aortic valve area and mean transaortic pressure gradient. [5] [6] [7] However, recent studies 8, 9 revealed that AS is not an isolated disease limited to the aortic valve but rather a concomitant disease influenced by global hemodynamic afterload imposed on the left ventricle. Briand et al 8 recently proposed valvuloarterial impedance (Zva), which estimates global left ventricular (LV) hemodynamic load as the sum of valvular and arterial loads. This global LV afterload causes LV impairments such as changes in LV geometry and myocardial damage, inducing LV diastolic and systolic dysfunction. [9] [10] [11] 
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Considering the complex relationship between the pathophysiology and clinical manifestations of AS, we hypothesized that Zva assessment could provide more information on syncope development. In this study, therefore, we assessed the effect of clinical and echocardiographic parameters, including Zva, on syncope in patients with AS.
Methods

Study Population
The present study was retrospectively designed. The study population comprised 1090 patients from the echocardiographic database of Cedars-Sinai Medical Center, CA, with at least moderate AS (mean transaortic pressure gradient ≥25 mm Hg on Doppler ultrasound) treated between January 2010 and May 2012.
Exclusion criteria comprised the following: age <50 years; low LV ejection fraction (LVEF; <40%); permanent or paroxysmal atrial fibrillation/flutter; pacemaker-dependent rhythm; structural heart disease, with fixed or dynamic mechanical outflow obstruction; previous open heart surgery (valve replacement or coronary artery bypass grafting) or transcatheter aortic valve replacement; coronary artery disease (history of myocardial infarction or percutaneous coronary intervention, coronary artery stenosis on coronary angiography, or regional wall motion abnormalities on echocardiography); chronic pulmonary disease; chronic renal failure (serum creatinine ≥2 mg/dL); and documented electrocardiographic abnormalities as follows: intraventricular conduction block (QRS duration ≥0.12 s), Mobitz second-or third-degree atrioventricular block, asymptomatic bradycardia, sinoatrial block or sinus pause (≥3 s), pre-excited QRS complex, and short-or long-QT interval. Patients who underwent echocardiographic examination on an unstable situation, such as acute decompensated heart failure, acute coronary syndrome, or acute pulmonary embolism, were also excluded.
The remaining 459 patients identified for analysis formed the study group ( Figure 1 ). The study protocol was approved by the Cedars-Sinai Medical Center Institutional Review Board.
Clinical Data
Clinical data included age; sex; body mass index; obesity (body mass index ≥30 kg/m 2 ); documented diagnosis of hypertension, diabetes mellitus, and hypercholesterolemia (with/without treatment); AS-related symptoms (syncope, dyspnea, and chest pain) 1 ; restricted mobility (eg, inability to walk because of a disabling stroke or advanced Parkinson disease); and New York Heart Association (NYHA) functional class, wherein mobility-restricted individuals were excluded from the total population for appropriate grade evaluation. In addition, patients were classified into the following 3 groups: patients with NYHA class I (ie, patients without symptoms and limitation of physical activity), those with class II/III (ie, patients with slight or marked limitation of physical activity), and those with class IV (ie, patients unable to perform any physical activity, such as those in a sedentary or bedridden state all day). After echocardiography, systemic blood pressure was measured in the supine position using a cuff-type sphygmomanometer.
Definition of Syncope in Patients With AS
The European Society of Cardiology defines syncope as transient loss of consciousness characterized by rapid onset, short duration, and spontaneous complete recovery. 12 In addition, presyncope is described as a state that resembles the prodrome of syncope but which is not followed by loss of consciousness in the guideline. 12 In the present study, syncope, including presyncope, was diagnosed by 2 physicians on the basis of medical records data. Syncopal episodes, diagnosed as neurally mediated syncope and consequential orthostatic hypotension, were included in the definition of syncope in patients with AS because of the possibility that AS triggers or potentiates a reflex mechanism. 2, 12 To clarify the relationship between syncope and clinical data, patients who had experienced syncope within 3 months before or after medical examination, including echocardiography, were selected. Consequently, 8 patients were excluded from the 459 patients because of the exclusion criterion. The final analysis included 451 patients ( Figure 1 ).
Echocardiography
Transthoracic echocardiography was performed by 2-dimensional Doppler echocardiography using a Philips iE33 ultrasound system (Philips Medical Systems, Andover, MA) in patients under a clinically stable condition. End-diastolic LV diameter, end-systolic LV diameter, end-diastolic ventricular septum thickness, and end-diastolic LV posterior wall thickness were measured in the parasternal long-axis view. Using the corrected American Society of Echocardiography formula, 13 LV mass was calculated and indexed for the body surface area. Relative wall thickness was calculated as twice the posterior wall thickness divided by LV end-diastolic dimension. 13 Left atrial volume was measured during LV end-systole using the biplane area-length method in the apical 2-and 4-chamber views; these measurements were indexed for body surface area (left atrial volume index). LVEF was calculated using the biplane method of discs (modified Simpson rule). 13 Stroke volume was calculated as the product of LV outflow tract area and velocity-time integral on pulsed-wave Doppler echocardiography of the LV outflow tract and was indexed for body surface area (stroke volume index [SVi]).
For AS severity assessment, peak and mean aortic velocities were obtained by continuous-wave Doppler echocardiography using a multiwindow approach, and corresponding pressure gradients were calculated using the modified Bernoulli equation. The aortic valve area was obtained using standard continuity equation and was indexed for body surface area (aortic valve area index). AS was defined as moderate or severe when the mean transaortic pressure gradient was ≥25 to 40 mm Hg or >40 mm Hg, respectively. 14 To assess diastolic function, peak early diastolic velocity (E), peak late diastolic velocity (A), and E/A ratio were derived from Doppler recordings of transmitral flow. Peak early diastolic mitral annular velocity (e′) of the lateral site of the mitral annulus was measured by tissue Doppler imaging. The ratio between E and e′ was calculated (E/e′) to estimate the LV filling pressure. 15 Zva was calculated as the sum of systolic blood pressure (SBP) and mean transaortic pressure gradient divided by the SVi. 9 We also calculated the ratio of SVi to brachial pulse pressure (SVi/PP) as an index of systemic arterial compliance. 16 Systemic vascular resistance was estimated using the following formula: (80×mean blood pressure)/cardiac output.
Statistical Analysis
IBM SPSS version 19.0 (SPSS Inc, Chicago, IL) was used. Continuous variables are expressed as mean±SD. Differences between continuous variables were assessed using the Student t test. Categorical variables are expressed as absolute values and frequency percentages and were compared using the χ 2 or Fisher exact test, as appropriate. Differences in continuous variables among ≥3 groups were assessed using 1-way ANOVA with the post hoc Tukey honestly significant difference test.
A forward stepwise multivariable logistic regression analysis was performed to identify the potential clinical and echocardiographic predictors of syncope in patients with AS. All parameters predicting syncope, with P<0.1 in univariable analysis, were incorporated into the multivariable model. In the multivariable analysis, variables were excluded from the model when P>0.10 in the stepwise procedure based on the likelihood ratio test. Odds ratios were provided with 95% confidence intervals. Receiver operating characteristic curve analysis was performed to determine the cutoff values of parameters predicting syncope in patients with AS. The area under the receiver operating characteristic curve of >0.7 was considered accurate. A 2-tailed P<0.05 was considered significant.
Results
Clinical Characteristics
Clinical characteristics are listed in Table 1 . Of the 451 patients with AS (mean age, 82±8 years), 79 (18%) had a history of syncope and 242 (54%) were men. Significantly fewer patients with syncope were mobility-restricted individuals (P=0.020); patients with syncope had a higher prevalence of NYHA class II/III (P<0.001) and a lower prevalence of class I (P=0.006) and class IV (P=0.027) than those without; no significant differences were observed in age, sex, body mass index, body surface area, SBP and diastolic blood pressure, cardiovascular risk factors, medical treatment, and symptoms of dyspnea and chest pain.
Echocardiographic Characteristics
Echocardiographic characteristics are listed in Table 2 . Of the 451 patients, 218 (48%) had moderate AS and 233 (52%) had severe AS. Mean transaortic pressure gradient tended to be higher in patients with syncope than in those without, but the difference did not reach statistical significance (P=0.076). Furthermore, no significant differences existed between the 2 groups as for the prevalence of severe AS and conventional parameters of AS severity, represented by the peak transaortic pressure gradient and the aortic valve area.
Patients with syncope had a lower SVi (P=0.001) and SVi/ PP (P=0.007) and a higher Zva (P<0.001) than those without. Patients with syncope tended to exhibit higher relative wall thickness and E/e′ ratio compared with those without; however, the difference did not reach statistical significance (0.05<P<0.1). A trend of smaller end-diastolic diameter was also found in patients with syncope, although this trend failed to reach statistical significance (P=0.123). LVEF and left atrial volume index were found to be similar between the 2 groups.
Comparison of Characteristics Among NYHA Classification Groups
Compared with patients with NYHA classes I and IV, patients with class II/III had a higher incidence of syncope (both P<0.05). Patients with NYHA class IV had a lower LVEF than the other 2 groups (both P<0.05). Patients with NYHA class II/III and class IV had a higher mean transaortic pressure gradient than those with class I (both P<0.05). E/e′ ratio and Zva were higher, and SVi was lower as NYHA class worsened (all P<0.05; Table 3 ). In addition, we compared Zva in patients with and without syncope among the 3 NYHA classification groups. In each group, patients with syncope had significantly higher Zva compared with those without (all P<0.05; Figure 2 ).
Predictors of Syncope in Patients With AS
Univariable logistic regression analysis showed that syncope was correlated with mobility-restricted individuals, SBP, relative wall thickness, E/e′ ratio, mean transaortic pressure gradient, SVi, SVi/PP, and Zva (all P<0.1). However, collinearity was observed among Zva, SVi, and SVi/PP. Therefore, Zva, which had the strongest correlation with syncope among the variables on univariable analysis, was incorporated into the multivariable model. In the multivariable analysis, only Zva was an independent predictor of syncope in patients with AS (odds ratio, 2.02; 95% confidence interval, 1.54-2.64; P<0.001; odds ratio, 2.02; 95% confidence interval, 1.54-2.64; P<0.001). However, mobility-restricted individuals, SBP, relative wall thickness, E/e′ ratio, and mean transaortic pressure gradient were not identified as independent predictors (Table 4 ). Figure 3 shows the receiver operating characteristic curve analysis of the ability of Zva, SBP, mean transaortic pressure gradient, and SVi to predict syncope in patients with AS. The area under the curve for Zva was found to be the largest among the parameters (area under the curve=0.71; P<0.001). The receiver operating characteristic curve analysis identified Zva ≥4.7 mm Hg/mL per m 2 (95% confidence interval, 0.66-0.77; P<0.001; sensitivity, 78.5%; specificity, 64.0%) as the cutoff value associated with syncope. Patients with high Zva (Zva ≥4.7 mm Hg/mL per m 2 ; n=193) had higher incidence of syncope than those with low Zva (Zva <4.7 mm Hg/mL per m 2 ; n=258; P<0.001; Figure 4A ). However, no significant difference in syncope occurrence existed between moderate and severe AS classified by mean transaortic pressure gradient (P=0.125; Figure 4B ). We also investigated the correlation between Zva and the ominous symptoms of AS in patients with high Zva (n=220) and low Zva (n=180). Patients with high Zva had a higher incidence of dyspnea than those with low Zva (35% versus 53%; P<0.001). In contrast, there was no difference in chest pain between the 2 groups (7% versus 10%; P=0.331).
Discussion
In this retrospective study, we identified Zva as an independent predictor of syncope in patients with AS. Furthermore, we observed that conventional parameters of AS severity, including mean transaortic pressure gradient and aortic valve area, were unable to independently predict syncope. To the best of our knowledge, this is the first study to determine predictors of syncope in patients with AS in the modern era. A indicates peak late diastolic velocity; E, peak early diastolic velocity; e′, peak early diastolic mitral annular velocity; LA, left atrial; LV, left ventricular; PP, pulse pressure; SVi, stroke volume index; and Zva, valvuloarterial impedance.
Syncope in Patients With AS
The onset of classical symptoms of AS, such as heart failure, angina, and syncope, is considered the main demarcation point in the prediction of grave prognosis in the natural course of AS, as reported by Ross and Braunwald 1 in 1968. During the past 5 decades, the prevalence of AS has increased with aging; furthermore, the main cause has markedly changed from rheumatic pathogenesis to arteriosclerosis. 17 Consequently, almost all current clinical studies of AS discuss patients aged >70 years, [7] [8] [9] 11 contrary to the average age of 48 years at clinical presentation reported by Ross and Braunwald. 1 It is natural to think that the perception from clinical studies of the past 18, 19 would not apply to the new condition in recent years; however, only few recent studies have investigated and reported on syncope in patients with AS. [2] [3] [4] Syncope is one of the most urgent clinical symptoms, occurring suddenly without warning. Restricted cardiac output caused by a narrowed aortic orifice with excessive progression was regarded as the major cause of syncope in patients with AS. However, reports mention that other mechanisms of syncope development in AS exist, such as inappropriate reflex vasodilation, which is possibly mediated by a sudden rise in LV pressure and an increase in LV wall stress, [2] [3] [4] or primary cardiac arrhythmia. 20 The timing of syncope development and range of syncope history differ with each cause, depending on distinct pathophysiological conditions in the progress of AS. Interestingly, Ross and Braunwald 1 mentioned that the prognostic range of syncope was generally wide, although the average duration for death after syncope is 3 years. In the present study, univariable analysis showed that several factors, such as SBP, relative wall thickness, E/e′ ratio, mean transaortic pressure gradient, SVi, SVi/PP, and Zva, were associated with syncope (P<0.1). However, contrary to expectations, multivariable analysis showed that the mean transaortic pressure gradient was not an independent predictor of syncope. These findings support the theory that multiple mechanisms, not just the severity of valve-specific factors as conventionally thought, underlie symptom development. 12 Furthermore, a recent study reported that no correlation was found between AS severity and LV mass index, 21 although LV hypertrophy by itself is associated with sudden death and syncope. 20, 22 This may also explain the lack of association between conventional parameters of AS severity and syncope.
Furthermore, it has been reported that symptoms often arise during exercise. 2, 3 In the present study, we found that activity limitation caused by restricted mobility or serious disease condition (NYHA class IV) had no significant relationship with syncope and that AS patients with NYHA class II/III, who could perform certain life activities and strain themselves, tended to experience syncope. Therefore, syncope may occur in patients with AS as a result of high Zva, which underlies multiple mechanisms that occur in daily life activities.
However, in a recent study to evaluate the association between symptoms in severe AS and the hemodynamics, AS patients with syncope had reduced output, along with smaller LV cavity. 23 In the present study, using multivariable analysis, we found that only Zva was associated with syncope. The cavity size tended to be smaller, but the difference did not reach statistical significance.
Effect of Valvuloarterial Impedance on Syncope in Patients With AS
Zva estimates global LV hemodynamic load as the sum of valvular and vascular loads. [8] [9] [10] Patients with chronic pressure overload and LV hypertrophy have increased LV wall stress, subendocardial ischemia, and stimulation of LV baroreceptors, 20 which may lead to hypotension and arrhythmias. From the viewpoint of LV overload, it seems natural that Zva is closely associated with syncope. However, a previous study in patients with hypertrophic cardiomyopathy reported that postural, nonexercise-related syncope may relate to incomplete filling as a result of LV diastolic dysfunction caused by myocardial hypertrophy and fibrosis. 24 Considering that severe diastolic dysfunction, myocardial hypertrophy, and fibrosis are usually observed in not only hypertrophic cardiomyopathy, but also severe AS, 11, 25 we speculate that a similar mechanism may cause syncope in patients with AS. Furthermore, as shown in the present study, Zva can actually predict syncope because of the total severity of AS beyond the capability of diastolic parameters such as E/A ratio and E/e′ ratio.
Our study suggests that Zva ≥4.7 mm Hg/mL per m 2 predicts syncope in patients with AS. In a previous study that included patients with moderate-to-severe AS, 8 Zva ≥4.5 mm Hg/mL per m 2 predicted LV diastolic dysfunction, and Zva ≥5 mm Hg/mL per m 2 predicted LV systolic dysfunction. Therefore, Zva ≥4.7 mm Hg/mL per m 2 may have clinical significance because it may represent not only the cutoff value of syncope prediction, but also an afterload level that surpasses the capabilities of the LV compensatory mechanism. A previous study reported that LVOT shape that was evaluated using 3-dimensional transesophageal echocardiography is generally not circular but frequently elliptical in patients with AS. 26 Hence, there is possibility of an important error in the assessment of stroke volume using 2-dimensional echocardiography because LVOT area (errors in the diameter measurement are squared) is calculated by assuming a circular geometry. Accurate measurements with 3-dimensional , systolic blood pressure (SBP), mean transaortic pressure gradient, and stroke volume index (SVi) to predict syncope in patients with aortic valve stenosis (AS). The best cutoff value of Zva to predict syncope in patients with AS is 4.7 mm Hg/mL per m 2 (arrow), with a sensitivity of 78.5% and a specificity of 64.0%. echocardiography may improve the proposed cutoff values in the future.
Furthermore, transcatheter aortic valve replacement has recently emerged as an alternative and less invasive therapy for patients with severe AS who are not candidates for surgical AVR. A recent study reported immediate improvements in Zva after transcatheter aortic valve replacement and suggested that preoperative Zva predicts the 6-month outcome. 27 It is expected that besides treatment with surgical AVR, more patients with AS will benefit from transcatheter aortic valve replacement. Thus, consideration of Zva may allow for better selection of patients with AS for transcatheter aortic valve replacement.
Clinical Implications
The present study suggests that AS patients with high Zva have an increased risk of syncope. Recently, Kang et al 28 reported that early surgery in asymptomatic patients with severe AS improved clinical outcomes compared with a wait for symptoms strategy. However, in patients with asymptomatic AS, it would be premature to perform AVR based on only high Zva.
Given that syncope is caused by multiple mechanisms, further investigation of other causes of syncope, such as arrhythmia and ischemia, should be conducted, in addition to a closer follow-up of the patients. Comprehensive evaluation of AS severity by integrating Zva into conventional parameters, such as mean transaortic pressure gradient, LVEF, and E/e′ ratio, may enable us to better select patients with asymptomatic AS for AVR. Further studies are needed to explore applicability of Zva to clinical practice, including the indication for AVR.
Limitations
The main limitation of the present study is its retrospective design. The syncope status of patients was determined by reviewing medical records alone. Therefore, we were unable to obtain further details to clarify its cause or completely eliminate transient arrhythmia or myocardial ischemia attack, resulting in syncope.
Another limitation is that the patient selection criterion was limited. Especially, to determine the relationship accurately between syncope and AS severity by transaortic pressure gradient, patients with LVEF <40% were excluded because a decreased transaortic pressure gradient caused by depressed LVEF may result in underestimation of AS severity. 29 Therefore, this study does not represent the complete population of patients with AS. Finally, prospective investigations are required to verify the power of Zva to predict syncope in patients with AS.
Conclusions
Our study suggests that high Zva, but not conventional parameters of AS, identifies patients with AS who have an increased risk of syncope.
